Navigation Links
Fish & Richardson Prevails in Patent Infringement Trial for Volcano Corporation
Date:10/31/2012

SAN DIEGO, Oct. 31, 2012 /PRNewswire/ -- Fish & Richardson scored a major victory for San Diego based Volcano Corporation in a patent trial regarding medical device technology used to diagnose heart problems.  After less than 90 minutes of deliberation, a federal district court jury in Delaware found that Volcano did not infringe two patents asserted by St. Jude Medical Inc. and that another two St. Jude patents were invalid.  A fifth St. Jude patent was declared not infringed by the court on the eve of trial.  The lawsuit, filed in 2010 by St. Jude, sought to shut down Volcano's rapidly growing cardiac Functional Management business.  The verdict was delivered on October 19, 2012 and was initially subject to an agreement by the parties not to issue press releases.

The Fish team was led by Frank Scherkenbach with assistance from principals Todd Miller, Michael Rosen, Michael Amon, Thomas Halkowski, and John Farrell and associate Corrin Drakulich.  St. Jude was represented by DLA Piper.

Volcano and St. Jude are competitors in the fast-growing pressure sensing guide wire business.  These wires are six feet long and two hairs thick and include a microscopic pressure-sensing chip.  Functional Management is a guide wire based technology that analyzes pressure and flow parameters from inside of the vessel.

"We are very pleased to deliver this significant victory for Volcano in its David vs. Goliath like lawsuit," stated Todd Miller of Fish & Richardson.  "Volcano is now free to once again focus on bringing its life saving technologies to patients."

The jury found that St. Jude Medical patents 6,112,598 (a sensor mount patent) and 6,248,083 (a calibration patent) were not infringed and patents 5,938,624 and 6,196,980 (connector patents) were invalid. 

In a separate trial heard the following week with the same legal teams, St. Jude admitted liability as to certain products and the jury found certain other St. Jude Medical products did not infringe Volcano's asserted patents. 

Fish & Richardson is a global law firm providing strategic counseling and litigation services to innovative clients who seek to protect and maximize the value of their intellectual property (IP).  With more than 375 attorneys and technology specialists practicing IP strategy and counseling, IP litigation, and business litigation, Fish is known for its superior technical expertise.  Visit www.fr.com or follow @fishrichardson on Twitter.

 

 


'/>"/>
SOURCE Fish & Richardson
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Keynote Presentation at Upcoming International Microbiology & Genomics Meeting to Highlight Ability of Pressure BioSciences Patented PCT Platform to Improve Testing for Biological Threat Organisms, Human Infectious Diseases, and Contaminated Food P
2. Johnson & Johnson Postpones Medical Devices & Diagnostics Review
3. Health Partner Sauna & Generation Rescue Partner to Bring Awareness of Infrared Sauna Benefits to Autism
4. The Informex Global Pharma Sourcing Event Announces New Sponsor & Speakers
5. Anesthesia Equipment and Associated Peripherals: Advanced, Patient-Friendly Devices Will Sustain Market Growth in Europe, States Frost & Sullivan
6. Johnson & Johnson to Host Medical Devices & Diagnostics Review
7. Avanir Pharmaceuticals Achieves Commercial Milestones & Provides Clinical Updates
8. Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies
9. ESTEVE Fosters R & D by Transferring its Center for Drug Discovery to the Science Park of Barcelona (PCB)
10. Johnson & Johnson Announces Plans to Establish Innovation Centers
11. Talyst Holds User Group Meeting & Two-Day Customer Education Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... Israel , May 27, 2016 ... an innovative biopharmaceutical company focused on late-stage drug ... Dexcel Pharma of pivotal batches required ... and Drug Administration (FDA). This follows Kitov,s ... Phase III trial successfully met its primary efficacy ...
(Date:5/26/2016)... A key trend that will ... of new treatments. Cardax, a development stage life sciences ... therapy is expected to fulfil large unmet medical needs ... studies to develop new treatments for osteoarthritis. One such ... in osteoarthritis are being investigated, and early trials of ...
(Date:5/25/2016)... 25,2016 FDA 510(k) clearance ... platform for urological and surgical applications ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) ... the US with the 12 th 510(k) ... (FDA). This new FDA clearance covers Confocal Miniprobes ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... On Memorial Day, Hope For ... their lives in military battle for the country. The nonprofit Hope For Heroes ... more programs that empower independence for disabled military veterans, as well as police, firemen, ...
(Date:5/26/2016)... , ... May 26, 2016 , ... MadgeTech will be ... engineered, and manufactured in Warner, New Hampshire at the MadgeTech headquarters. With products sold ... monitoring solutions trusted by government agencies, including NASA. , In 2012, NASA strategically ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... In an effort to provide hair restoration ... to both Snapchat users and those who do not use the app. Dr. Mohebi, the ... new page, Dr. Mohebi Live . , Dr. Mohebi says, “The positive response ...
(Date:5/26/2016)... Tampa, Fla. (PRWEB) , ... May 26, 2016 , ... ... Center (AHEC) to host a six-week smoking cessation class starting June 6 at their ... AHEC’s website, http://www.gnahec.org . , Additionally, the Lung Institute has created a free ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... The MIAMI ... events featuring guest speaker Dr. Adonis Maiquez MD, ABAARM. Dr. Adonis , Wellness ... Regenerative Medicine, and a member of the Institute for Functional Medicine. , He also ...
Breaking Medicine News(10 mins):